Low-Dose Rituximab Effective for Acquired Thrombotic Thrombocytopenic Purpura With Severe ADAMTS13 Deficiency

Press/Media

Period	25 Feb 2019

Media coverage

Title	Low-Dose Rituximab Effective for Acquired Thrombotic Thrombocytopenic Purpura With Severe ADAMTS13 Deficiency
Media name/outlet	The ASCO Post (in partnership with the American Society of Clinical Oncology)
Country/Territory	United States
Date	25/02/19
URL	https://ascopost.com/issues/february-25-2019-supplement-conference-highlights-ash-2018/low-dose-rituximab-effective-for-acquired-thrombotic-thrombocytopenic-purpura-with-severe-adamts13-deficiency/
Persons	Joshua Muia